Alia Lilienstein, MD, MPH

Alia Lilienstein, MD, MPH

Director of Clinical Research

Alia Lilienstein, MD, MPH, is a board-certified Family Medicine physician with over a decade of experience in psychedelic research.

She is a Research Physician at UC Berkeley Center for the Science of Psychedelics, providing medical, regulatory, and operational oversight of psychedelic human studies and conducting study visits, including dosing sessions.

She spent eight years at Lykos Therapeutics as clinical lead for the Phase 3 trials and 2024 FDA New Drug Application for MDMA-assisted therapy for PTSD. She holds an MPH from UC Berkeley, MD from Mount Sinai, residency at Cambridge Health Alliance, and a certificate in Psychedelic-Assisted Therapy and Research from the California Institute of Integral Studies.